Endometriosis: causes, diagnosis, and treatment options-review article for healthcare providers

Sahar Adi Albogamy; ‏Mohammed Abdullah AlZaher; ‏Hussain Mahdi Aljawad; ‏Ali Suliman Al Aloula; ‏Barakat Shumailan Alazmiy; ‏Fahad Abdulaziz Bahaidarah; Mohammad Shabib Alharbi; Mohammad Raja Aljehani; Fouad Hamed Alamri

doi:10.53730/ijhs.v2nS1.15234

Authors

Sahar Adi Albogamy KSA, National Guard Health Affairs
‏Mohammed Abdullah AlZaher KSA, National Guard Health Affairs
‏Hussain Mahdi Aljawad KSA, National Guard Health Affairs
‏Ali Suliman Al Aloula KSA, National Guard Health Affairs
‏Barakat Shumailan Alazmiy KSA, National Guard Health Affairs
‏Fahad Abdulaziz Bahaidarah KSA, National Guard Health Affairs
Mohammad Shabib Alharbi KSA, National Guard Health Affairs
Mohammad Raja Aljehani KSA, National Guard Health Affairs
Fouad Hamed Alamri KSA, National Guard Health Affairs

Keywords:

Endometriosis, chronic pain, subfertility, diagnosis, treatment options, epidemiology

Abstract

Background: Endometriosis is characterized by the presence of functional, estrogen-responsive endometrial-like tissue outside the uterine cavity, leading to chronic inflammation and significant impairment of quality of life. Its economic burden in the United States exceeds $49 billion, driven largely by healthcare costs and productivity losses for affected individuals. Aim: This review aims to provide healthcare providers with a comprehensive understanding of endometriosis, including its causes, epidemiology, pathophysiology, clinical presentation, diagnosis, and treatment options. Methods: A review of current literature was conducted to gather information on the various aspects of endometriosis, including genetic, environmental, and epidemiological factors, along with its mechanisms of pain and subfertility. Results: Endometriosis affects approximately 6–10% of reproductive-aged women and is associated with risk factors such as early menarche and nulliparity. The condition presents with diverse symptoms, including dysmenorrhea and subfertility. Diagnosis is confirmed through surgical visualization and biopsy of lesions. The pathophysiology includes aberrant immune responses and hormonal dysregulation, contributing to chronic pain and infertility. Conclusion: Understanding the complexities of endometriosis is crucial for effective diagnosis and treatment. Given its multifactorial nature and significant impact on women's health, ongoing research is essential to improve treatment strategies and patient outcomes.

Downloads

Download data is not yet available.

References

Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 2012;27:1292–9. DOI: https://doi.org/10.1093/humrep/des073

Balasch J, Creus M, Fábregues F, Carmona F, Ordi J, Martinez-Román S, et al. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum Reprod 1996;11:387–91. DOI: https://doi.org/10.1093/HUMREP/11.2.387

Carter JE. Combined hysteroscopic and laparoscopic findings in patients with chronic pelvic pain. J Am Assoc Gynecol Laparosc 1994;2:43–7. DOI: https://doi.org/10.1016/S1074-3804(05)80830-8

Kavoussi SK, Odenwald KC, As-Sanie S, Lebovic DI. Incidence of ovarian endometrioma among women with peritoneal endometriosis with and without a history of hormonal contraceptive use. Eur J Obstet Gynecol Reprod Biol 2017;215:220–3. DOI: https://doi.org/10.1016/j.ejogrb.2017.06.028

Rahmioglu N, Nyholt DR, Morris AP, Missmer SA, Montgomery GW, Zondervan KT. Genetic variants underlying risk of endometriosis: insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update 2014;20:702–16. DOI: https://doi.org/10.1093/humupd/dmu015

Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol 2011;118:691–705. DOI: https://doi.org/10.1097/AOG.0b013e31822adfd1

Bulun SE, Monsivais D, Kakinuma T, Furukawa Y, Bernardi L, Pavone ME, et al. Molecular biology of endometriosis: from aromatase to genomic abnormalities. Semin Reprod Med 2015;33:220–4. DOI: https://doi.org/10.1055/s-0035-1554053

Nothnick WB, Falcone T, Joshi N, Fazleabas AT, Graham A. Serum miR-451a levels are significantly elevated in women with endometriosis and recapitulated in baboons (Papio anubis) with experimentally-induced disease. Reprod Sci 2017;24:1195–1202. DOI: https://doi.org/10.1177/1933719116681519

Muzii L, Bianchi A, Bellati F, Cristi E, Pernice M, Zullo M, et al. Histologic analysis of endometriomas: what the surgeon needs to know. Fertil Steril 2007;87:362–6. DOI: https://doi.org/10.1016/j.fertnstert.2006.06.055

Aredo JV, Heyrana KJ, Karp BI, Shah JP, Stratton P. Relating chronic pelvic pain and endometriosis to signs of sensitization and myofascial pain and dysfunction. Semin Reprod Med 2017;35:88–97. DOI: https://doi.org/10.1055/s-0036-1597123

As-Sanie S, Kim J, Schmidt-Wilcke T, Sundgren PC, Clauw DJ, Napadow V, et al. Functional connectivity is associated with altered brain chemistry in women with endometriosis-associated chronic pelvic pain. J Pain 2016;17:1–13. DOI: https://doi.org/10.1016/j.jpain.2015.09.008

Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility. Fertil Steril 2010;94:1894–9. DOI: https://doi.org/10.1016/j.fertnstert.2009.09.043

Matorras R, Corcostegui B, Esteban J, Ramon O, Prieto B, Expósito A, et al. Fertility in women with minimal endometriosis compared with normal women was assessed by means of a donor insemination program in unstimulated cycles. Am J Obstet Gynecol 2010;203:345.e1–6. DOI: https://doi.org/10.1016/j.ajog.2010.05.019

Prapas Y, Goudakou M, Matalliotakis I, Kalogeraki A, Matalliotaki C, Panagiotidis Y, et al. History of endometriosis may adversely affect the outcome in menopausal recipients of sibling oocytes. Reprod Biomed Online 2012;25:543–8. DOI: https://doi.org/10.1016/j.rbmo.2012.07.020

Kitajima M, Dolman MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicle recruitment and atresia in cortex derived from ovaries with endometrioma. Fertil Steril 2014;101:1031–7. DOI: https://doi.org/10.1016/j.fertnstert.2013.12.049

Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol 2016;215:589.e1–6. DOI: https://doi.org/10.1016/j.ajog.2016.05.029

Chapron C, Santulli P, de Ziegler D, Noel JC, Anaf V, Streuli I, et al. Ovarian endometrioma: severe pelvic pain is associated with deeply infiltrating endometriosis. Hum Reprod 2012;27:702–11. DOI: https://doi.org/10.1093/humrep/der462

Guerriero S, Condous G, van den Bosch T, Valentin L, Leone FP, Van Schoubroeck D, et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol 2016;48:318–32. DOI: https://doi.org/10.1002/uog.15955

Abrao MS, Gonçalves MO, Dias JA Jr, Podgaec S, Chamie LP, Blasbalg R. Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 2007;22:3092–7. DOI: https://doi.org/10.1093/humrep/dem187

Bazot M, Malzy P, Cortez A, Roseau G, Amouyal P, Daraï E. Accuracy of transvaginal sonography and rectal endoscopic sonography in the diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol 2007;30:994–1001. DOI: https://doi.org/10.1002/uog.4070

Bazot M, Bornier C, Duberbnard G, Roseau G, Cortez A, Daraï E. Accuracy of magnetic resonance imaging and rectal endoscopic sonography for the prediction of location of deep pelvic endometriosis. Hum Reprod 2007;22:1457–63. DOI: https://doi.org/10.1093/humrep/dem008

Ahn SH, Singh V, Tayade C. Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 2017;107:523–32. DOI: https://doi.org/10.1016/j.fertnstert.2017.01.009

Nisenblat V, Prentice L, Bossuyt PM, Farquhar C, Hull ML, Johnson N. Combination of the non-invasive tests for the diagnosis of endometriosis. The Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD012281. DOI: 10.1002/14651858.CD012281. DOI: https://doi.org/10.1002/14651858.CD012281

Management of endometriosis. Practice Bulletin No. 114. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;116:223–36. DOI: https://doi.org/10.1097/AOG.0b013e3181e8b073

Bedaiwy MA, Pope R, Henry D, Zanotti K, Mahajan S, Hurd W, et al. Standardization of laparoscopic pelvic examination: a proposal of a novel system. Minim Invasive Surg 2013;2013:153235. DOI: https://doi.org/10.1155/2013/153235

Practice Committee of the American Society for Reproductive Medicine. Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril 2014;101:927–35. DOI: https://doi.org/10.1016/j.fertnstert.2014.02.012

Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009;15:441–61. DOI: https://doi.org/10.1093/humupd/dmp007

Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril 2008;90:1583–8. DOI: https://doi.org/10.1016/j.fertnstert.2007.08.051

Muzii L, Di Tucci C, Achilli C, Di Donato V, Musella A, Palaia I, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol 2016;214:203–11. DOI: https://doi.org/10.1016/j.ajog.2015.08.074

Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017;107:533–6. DOI: https://doi.org/10.1016/j.fertnstert.2017.01.003

Vercellini P, Bracco B, Mosconi P, Roberto A, Alberico D, Dhouha D, et al. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertil Steril 2016;105:734–43.e3. DOI: https://doi.org/10.1016/j.fertnstert.2015.11.016

Crosignani PG, Luciano A, Ray A, Bergqvist A. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reprod 2006;21:248–56. DOI: https://doi.org/10.1093/humrep/dei290

Brown J, Pan A, Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. The Cochrane Database of Systematic Reviews 2010, Issue 12. Art. No.: CD008475. DOI: 10.1002/14651858.CD008475.pub2. DOI: https://doi.org/10.1002/14651858.CD008475

Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993;60:75–9. DOI: https://doi.org/10.1016/S0015-0282(16)56039-7

Alkatout I, Mettler L, Beteta C, Hedderich J, Jonat W, Schollmeyer T, et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol 2013;20:473–81. DOI: https://doi.org/10.1016/j.jmig.2013.01.019

Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, et al. Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist. N Engl J Med 2017;377:28–40. DOI: https://doi.org/10.1056/NEJMoa1700089